Cytokines and heart failure - PubMed (original) (raw)
Affiliations
- PMID: 12634874
Review
Cytokines and heart failure
W J Paulus. Heart Fail Monit. 2000.
Abstract
In many forms of cardiomyopathic left ventricular (LV) dysfunction, there is a rapid myocardial expression of pro-inflammatory cytokines such as interleukin 1, interleukin 6 and tumour necrosis factor-alpha (TNF-alpha) which mediate, via specific receptors, various processes such as gene expression, cell growth or apoptosis. In the initial stages of myocarditis, the myocardial expression of proinflammatory cytokines appears to be part of an inflammatory process. In many other conditions such as ischaemic cardiomyopathy and chronic LV pressure or volume overload, myocardial expression of proinflammatory cytokines is triggered by an elevation of LV wall stress. Myocardial expression of cytokines contributes to depression of contractile performance and adverse LV remodelling. Cytokine-induced depression of contractile performance appears to result from sphingosine production, which interferes with myocardial calcium handling. In transgenic mice, the rate of progression of LV dilatation appears to correlate with the intensity of myocardial TNF-alpha overexpression. In heart failure patients, cytokine concentrations are elevated not only in the myocardium but also in plasma. Cytokines are, therefore, responsible not only for autocrine and paracrine signalling within the myocardium but also for endocrine signalling throughout the body, especially affecting striated muscle mass with induction of muscle wasting and cachexia. The source of cytokine production in heart failure remains uncertain and several mechanisms have been proposed including endotoxin-induced immune activation due to bowel oedema, myocardial production due to haemodynamic overload and peripheral extramyocardial production due to tissue hypoperfusion and hypoxia. The latter seems to be the most likely mechanism, possibly modulated by the presence of bacterial endotoxins released from the gut. Numerous drugs have meanwhile been shown to influence this cardioinflammatory response to heart failure either by reducing basal levels of cytokines (e.g. amlodipine, pentoxifylline, beta-blockers) or by reducing endotoxin-induced cytokine gene expression (e.g. ouabain, amiodarone, adenosine, angiotensin converting enzyme inhibitors, angiotensin II-receptor blockers). Direct blockade of the deleterious actions of elevated plasma levels of cytokines recently became possible through intravenous infusion of a soluble TNF-alpha receptor fusion protein, which resulted in an increase in exercise tolerance and LV performance.
Similar articles
- Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
Stumpf C, Petzi S, Seybold K, Wasmeier G, Arnold M, Raaz D, Yilmaz A, Daniel WG, Garlichs CD. Stumpf C, et al. Clin Sci (Lond). 2009 Jan;116(1):45-52. doi: 10.1042/CS20080042. Clin Sci (Lond). 2009. PMID: 18459941 - Myocardial cytokine gene expression is higher in aortic stenosis than in idiopathic dilated cardiomyopathy.
Vanderheyden M, Paulus WJ, Voss M, Knuefermann P, Sivasubramanian N, Mann D, Baumgarten G. Vanderheyden M, et al. Heart. 2005 Jul;91(7):926-31. doi: 10.1136/hrt.2004.035733. Heart. 2005. PMID: 15958363 Free PMC article. - Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
Mayer B, Holmer SR, Hengstenberg C, Lieb W, Pfeifer M, Schunkert H. Mayer B, et al. Int J Cardiol. 2005 Aug 18;103(2):182-6. doi: 10.1016/j.ijcard.2004.08.053. Int J Cardiol. 2005. PMID: 16080978 - Oxidative stress and left ventricular remodelling after myocardial infarction.
Hori M, Nishida K. Hori M, et al. Cardiovasc Res. 2009 Feb 15;81(3):457-64. doi: 10.1093/cvr/cvn335. Epub 2008 Dec 1. Cardiovasc Res. 2009. PMID: 19047340 Review. - The importance of tumor necrosis factor and lipoproteins in the pathogenesis of chronic heart failure.
Sharma R, Al-Nasser FO, Anker SD. Sharma R, et al. Heart Fail Monit. 2001;2(2):42-7. Heart Fail Monit. 2001. PMID: 12634890 Review.
Cited by
- Regional hippocampal damage in heart failure.
Woo MA, Ogren JA, Abouzeid CM, Macey PM, Sairafian KG, Saharan PS, Thompson PM, Fonarow GC, Hamilton MA, Harper RM, Kumar R. Woo MA, et al. Eur J Heart Fail. 2015 May;17(5):494-500. doi: 10.1002/ejhf.241. Epub 2015 Feb 22. Eur J Heart Fail. 2015. PMID: 25704495 Free PMC article. - Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction.
Abernethy A, Raza S, Sun JL, Anstrom KJ, Tracy R, Steiner J, VanBuren P, LeWinter MM. Abernethy A, et al. J Am Heart Assoc. 2018 Apr 12;7(8):e007385. doi: 10.1161/JAHA.117.007385. J Am Heart Assoc. 2018. PMID: 29650706 Free PMC article. Clinical Trial. - Cardiac Remodeling: Endothelial Cells Have More to Say Than Just NO.
Segers VFM, Brutsaert DL, De Keulenaer GW. Segers VFM, et al. Front Physiol. 2018 Apr 11;9:382. doi: 10.3389/fphys.2018.00382. eCollection 2018. Front Physiol. 2018. PMID: 29695980 Free PMC article. Review. - Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling.
Pan J, Guleria RS, Zhu S, Baker KM. Pan J, et al. J Clin Med. 2014 Jun 4;3(2):566-94. doi: 10.3390/jcm3020566. J Clin Med. 2014. PMID: 26237391 Free PMC article. Review. - Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice.
Reifenberg K, Lehr HA, Torzewski M, Steige G, Wiese E, Küpper I, Becker C, Ott S, Nusser P, Yamamura K, Rechtsteiner G, Warger T, Pautz A, Kleinert H, Schmidt A, Pieske B, Wenzel P, Münzel T, Löhler J. Reifenberg K, et al. Am J Pathol. 2007 Aug;171(2):463-72. doi: 10.2353/ajpath.2007.060906. Epub 2007 Jun 7. Am J Pathol. 2007. PMID: 17556594 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical